Contract award
SRI INTERNATIONAL
CONTRACT #HHSN272201800001I; SRI INTERNATIONAL; GMP MANUFACTURING OF OXFENDAZOLE CLINICAL TRIAL MATERIAL AND STABILITY STUDY; OA TASK 75N93021F00006; MIS TASK TOIA21C13PIPB-1; BASE AWARD; CAN 8470036; TOTAL $381,002.00
- PIID
- 75N93021F00006
- Award key
- CONT_AWD_75N93021F00006_7529_75N93018D00001_7529
- Recipient UEI
- SRG2J1WS9X63
- Parent award
- CONT_IDV_75N93018D00001_7529
- Source as of
- —
Current award value
$630,6043
Obligated to date
$630,6042
Potential with options
$630,6043
- Awarding agency
- Department of Health and Human ServicesNational Institutes of Health
- Contractor
- SRI INTERNATIONAL
- Place of performance
- Menlo Park, California
- Set-aside
- None
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full and Open Competition1 offers received
- Period of performance
- Jul 27, 2021 — Jun 2, 2025Through Jun 2, 2025 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Jul 27, 2021 | Initial award | $381,002.00 | $630,604.13 |
| P00001 | Sep 6, 2022 | M | $0.00 | $630,604.13 |
| P00002 | Nov 18, 2022 | C | $5,973.00 | $630,604.13 |
| P00003 | Nov 21, 2022 | G | $110,881.00 | $630,604.13 |
| P00004 | Nov 16, 2023 | G | $64,618.00 | $630,604.13 |
| P00005 | Nov 14, 2024 | G | $72,349.00 | $630,604.13 |
| P00006 | Jun 4, 2025 | F | $0.00 | $630,604.13 |
| P00007 | Sep 10, 2026 | C | -$4,218.87 | $630,604.13 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
| contractor_id | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
| current_award_value | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
| naics_code | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
| potential_award_value | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
| psc_code | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
| total_obligated | USAspending.gov | — | Sep 12, 2026 | usaspending_contract_csv@2026.08.2 | 7583cfe144a2 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 8 transaction records parsed from USAspending.gov, retrieved Sep 12, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.